The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 107, Issue 5, Pages -
Publisher
Oxford University Press (OUP)
Online
2015-02-26
DOI
10.1093/jnci/djv034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression
- (2013) Altaf A Dar et al. JNCI-Journal of the National Cancer Institute
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations
- (2012) J. G. Greger et al. MOLECULAR CANCER THERAPEUTICS
- Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
- (2012) Akihiro Fujimoto et al. NATURE GENETICS
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Events That Shape the Cancer Epigenome
- (2012) R. J. H. Ryan et al. SCIENCE
- Chromatin remodeling complex NURF regulates thymocyte maturation
- (2011) J. W. Landry et al. GENES & DEVELOPMENT
- Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
- (2011) Siân Jones et al. HUMAN MUTATION
- miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein
- (2011) Altaf A. Dar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Exome sequencing identifies GRIN2A as frequently mutated in melanoma
- (2011) Xiaomu Wei et al. NATURE GENETICS
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Chromatin remodelling during development
- (2010) Lena Ho et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype
- (2010) Yosef Buganim et al. PLoS One
- The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
- (2010) E. W. Joseph et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Biology of Chromatin Remodeling Complexes
- (2009) Cedric R. Clapier et al. Annual Review of Biochemistry
- Diallyl trisulphide-induced apoptosis in human melanoma cells involves downregulation of Bcl-2 and Bcl-xL expression and activation of caspases
- (2009) C. Zhou et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Alternative Splicing of NURF301 Generates Distinct NURF Chromatin Remodeling Complexes with Altered Modified Histone Binding Specificities
- (2009) So Yeon Kwon et al. PLoS Genetics
- Essential Role of Chromatin Remodeling Protein Bptf in Early Mouse Embryos and Embryonic Stem Cells
- (2008) Joseph Landry et al. PLoS Genetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now